Inhibition of androgen receptor and Cdc25A phosphatase as a combination targeted therapy in molecular apocrine breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/20605569

Cancer Lett. 2010 Dec 1 298 1 74-87

Download in:

View as

General Info

PMID
20605569